Oral complications of cancer chemotherapy;Complicações bucais da quimioterapia antineoplásica

Acta Scientiarum - Biological and Health Sciences

Volumn 24, Issue 3, 2002, Pages 663-670

  De Castro Martinez Martins, Adriane ^a   Pialarissi Caçador, Neil ^b   Penteado Gaeti, Walderez ^b  

^a UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Adverse effects; Chemotherapy; Oral complications

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANASTROZOLE; ANTINEOPLASTIC AGENT; BETA INTERFERON; BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FADROZOLE; FLUOROURACIL; HYDROXYUREA; MARIMASTAT; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MITHRAMYCIN; MITOMYCIN; PROCARBAZINE; THIOTEPA; TIOGUANINE; TOSITUMOMAB; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; VOROZOLE;

ARTICLE; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CYTOTOXICITY; DENTIST; GINGIVITIS; GLOSSITIS; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; MOUTH DISEASE; MOUTH ULCER; MUCOSA INFLAMMATION; MYCOSIS; NEUROTOXICITY; PAROTID GLAND DISEASE; STOMATITIS; VIRUS INFECTION; XEROSTOMIA;

BACTERIA (MICROORGANISMS); HERPES; HERPES ZOSTER;

EID: 0036626650     PISSN: 14156814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. BALMER, C.; VALLEY, A. W. Basic principles of cancer treatment and Cancer chemotherapy. In: DIPIRO, J. T. et al. Pharmacotherapy: a pathophysiologic approach. 3.ed. Stamford: Appleton e Lange, 1996. chap.119, p.2403-2465
2. BRASIL. MINISTÉRIO DA SAÚDE, INSTITUTO NACIONAL DO CÂNCER. O problema do câcer no Brasil. 4.ed Rio de Janciro: Coordenação de programas de controle de câncer - pro-onco, 1997.
3. BRASIL. MINISTÉRIO DA SAÚDE - DATA SUS. Epidemiologia do Câncer no Barsil Disponível em: http://www.inca.org.br/epidemiologia/estimativa2001/introdu cao.html.2001. 〈Acessado em 16 de março de 2001〉
4. BRINCKER, H.; CHRISTENSEN, B. E. Acute mucotaneous toxicity following high-dose hydroxyurea. Cancer Chemother. Pharmacol., Berlin, v.32, n.6, p.496-497, 1993.
5. BUNETEL, L.; BONNAURE-MALLET, M. Oral pathoses caused by Candida albicans during chemotherapy: Update on development mechanisms. Oral. Surg. Oral. Med. Oral. Pathol., St. Louis, v.82, n.2, p.161-165, 1996.
6. CALABRESI, P.; CHABNER, B. A. Quimioterapia das doenças neoplásicas. In: GOODMAN & GILMAN (Ed.). As bases farmacológicas da terapêutica. 9.ed. Rio de Janeiro: McGraw-Hill, 1996. Seção 10. p.903-907
7. CARL, W. Oral complications of local and systemic cancer treatment. Curr. Opin. Oncol., Hagerstown, v.7, n.4, p.320-4, 1995.
8. CHIODO, G. T. et al. The dentist's role in end-of life care. Gen. Dent., Chicago, v.46, n.6, p.560-565, 1998.
9. COLEMAN, S. An overview of oral complications of adult patients with malignant haematological conditions who have undergone radiotherapy or chemotherapy. J Adv. Nurs., Oxford, v.22, n.6, p.1085-1091, 1995.
10. DEPAOLA, L. G. Dental care for patients receiving chemotherapy. J. Am. Dent. Assoc., Chicago, v.112, n.2, p.198-203, 1986.
11. DENS, F. et al. Dental caries, gingival health, and oral hygiene of long term survivors of paediatric malignant diseases. Arch. Dis. Child., London, v.72, n.2, p.129-132, 1995.
12. DODD, M. J. et al. Comparison of methods to determine the prevalence and nature of oral mucositis. Cancer Practies, New York, v.4, n.6, p. 312-318, 1996.
13. DODD, M. J. et al. Risk factors for chemotherapy-induced oral mucositis: dental appliances, oral hygiene, previous oral lesions, and history of smoking. Cancer Investig., Monticella, v.17, n.4, p.278-284, 1999.
14. DREIZEN, S. Drogas antineoplésicas. In: NEIDLE, E.A.: YAGIELA, J.A. (Ed.). Farmacologia e terapéutica para dentistas. Rio de Janeiro: Guanabara Kogan, 1991. cap.40, p.463-475.
15. EPSTEIN, J. B.: SHUBERT, M. M. Oral mucositis in myelossupressive cancer therapy. Oral. Surg. Oral. Med. Oral. Pathol., St. Louis, v.88, n.3, p.273-276, 1999.
16. FOCAZIO B. M. S. Mucositis. Am. J. Nurs., Philadelphia, v.97, n.12, p.48-49, 1997.
17. GOBETTI, J. P. Prevention and Management of Oral complications of chemotherapy. Dent Assis., v.62, n.1, p.31-33, 1993.
18. GRAHAM, K. M. et al. Reducing the incidence of stomatitis using a quality assessment and improvement approach. Cancer Nurs., Philadelphia, v. 16, n.2, p.117-122, 1993.
19. HOLMES, S. The oral complications of specific anticancer therapy. Int. J. Nurs. Stud., Oxford, v.28, n.4, p.343-360, 1991.
20. HOLMES, S. Xerostomia: aetiology and management in cancer patients. Support Care Cancer, New York, v.6, n.4, p.348-55, 1998.
21. HOUSTON, D. Supportive therapies for cancer chemotherapy patients and the role of the oncology nurse. Cancer Nurs., Philadelphia, v.20, n.6, p.409-413, 1997.
22. IWAMOTO, R. R. A Nursing perspective on radiation-induced xerostomia. Oncology, Huntington, v.10, n.3, p.12-5, 1996.
23. KARTHAUS, M. et al. Prophylaxis and treatment of chemo and radiotherapy - induced oral mucositis - are there new strategies? Bone Marrow Transpl., Hampshire, v.24, n.10, p.1095-1108, 1999.
24. KOROLKOVAS, A. Agentes Antineoplásicos In: KOROLKOVAS, A. Dicionário Terapêutico. 95/96.ed. Rio de Janeiro: Guanabara, 1995. cap.12, p.12.01-12.27
25. LAINE, P. O. et al. Oral infection as a reason for febrile episodes in lymphoma patients receiving cytostatic drugs. Eur. J. Cancer, Kidlington, v.28B, n.2, p.103-107, 1992.
26. LEVINE, R. S. Saliva: 1. The nature of saliva. Dental Update., April, p. 120-126, 1989
27. LUNN, R. Oral mangement of the cancer patient. Part II: chemotherapy. Probe, Adelaide, v.32, n.2, p.58-65, 1998.
28. MADEYA, M. L. Oral complications from cancer therapy: Part 1 - Pathophysiology and secondary complications. Oncol. Nurs. Forum, New York, v.23, n.5, p.801-807, 1996.
29. MCCARTHY, G. M. et al. Risk factors associated with mucositis en cancer patients receiving 5-fluoracil. Oral Oncol., Kidlington, v.34, n.6, p484-490, 1998.
30. MCGUIRE, D. B. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol. Nurs. Forum, New York, v.20, n.10, p1493-1502, 1993.
31. MEALEY, B. L. et al. Dentistry and the cancer patient: part 1 - oral manifestantions and complications of chemotherapy. Compendium, Janesburg, v.15, n.10, p.1252, 1994.
32. MICROMEDEX® Healthcare Series Vol. 109 Copyright © MICROMEDEX Inc. 1974 - 2001 expires 9/2001.
33. MILLER, S. C. et al. Changing oral care need in the United States: The continuing need for oral medicine. Oral Surg. Oral Med. Oral Pathol., St. Louis, v.91, n.1, p.34-44, 2001.
34. MINISTÉRIO DA SAÚDE. SECRETARIA DE VIGILÂNCIA SANITÁRIA. Denominação Comum Brasileira (DCB). Listagem por Ordem Alfabética dos Compostos. Ago/1993.
35. MORAN, P. Cellular Effects of Cancer Chemotherapy Administration. J. Intrav. Nurs., Philadelphia, v.23, n.1, p.44-54, 2000.
36. MORRISON, V. A. et al. Impact of therapy with chlorambucil, fludarabine or fludarabine plus chlorambucil on infections in patients with chronic Lymphocytic Leukemia intergroup study center and leukemia group B9011. J. Clin. Oncol., Philadelphia, v.19, n.16, p.3611-3621, 2001.
37. NATIONAL CANCER INSTITUTE - NCI. Preparing patients for cancer therapy. J. Am. Dent. Assoc., Chicago, v.127, n.4, p.432-433, 1996.
38. NOHIC-NATIONAL ORAL HEALTH INFORMATION CLEARINGHOUSE. Oral Complications of cancer treatment: What the Oral Health Team can Do. Disponível em: http://www.nohic.nidcr.nih.gov/campaign/denfact. htm, 2001. 〈Acessado em 16 de março de 20017rang;.
39. NAYLOR, G. D. et al. Glossodynia after radiation therapy and chemotherapy. Ear Nose Throat J., Cleveland, v.68, n.10, p.751-757, 1989.
40. PARULEKAR, W. et al. Scoring oral mucositis. Oral Oncol, v.34, n.1998, p.63-71, 1998.
41. PETERSON, D. E.; D'AMBROSIO, J. A. Diagnosis and management of acute and chronic oral complications of nonsurgical cancer therapies. Dent. Clin. N. Am., Philadelphia, v.36, n.4, p.945-966, 1992.
42. ROSEMBERG, S.W. Oral complications of cancer chemotherapy- a review of 398 patients. J. Oral Med., Pouglakeepie, v.41, n.2, p.93-97, 1986.
43. SEMBA, S.E. et al. Dentistry and the cancer patient: Part 2 - Oral health management of the chemotherapy patient. Compendium, Janesburg, v.15, n.11, p.1378,1380-1387, 1994.
44. SILVA, A. M. R. et al. Manual de detecçao de lesões suspeitas. 2.ed. Rio de janeiro: Instituto Nacional do Câncer (INCA). Coordenadoria de programas de controle do câncer (pro-onco), 1996. p.07-10
45. SILVERMAN, S. Oral cancer: Complications of therapy. Oral Surg., Oral Med., Oral Pathol., St. Louis, v.88, n.2, p.122-126, 1999.
46. SIXOU, J-L. et al. The effects of chemoterapy on the supragingival plaque of pediatric cancer patients. Oral Oncol., Kidlington, v.34, n.1998, p.476-483, 1998.
47. SOLAL-CÉLIGNY, P. Estomatite. In: BÉNICHOU, C. Guia prático de Farmacovigilância, 2.ed. São Paulo: Andrei, 1999. cap12, p.263-266
48. SONIS, S. T. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol., Kidlington, v.34, n.1998, p.39-43, 1998.
49. SONIS, S.; CLARK, J. Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology, Basel, v.5, n.12, p.11-18, 1991.
50. SONIS, S. T. et al. Complicações bucais da quimioterapia do câncer. In: SONIS, S. T. et al. (Ed.). Princípios e prática de medicina oral. 2.ed. Rio de Janeiro: Guanabara Koogan, 1996. cap42, p.348-401
51. SONIS, S. T. et al. An animal model for mucositis induced by cancer therapy. Oral Surg. Oral Med., Oral Pathol, St. Louis, v.69, n.4, p.437-443, 1990.
52. SPIJKERVET, F. K; SONIS, S. T. New frontiers in the management of chemotherapy-induced mucositis. Curr Opin. Oncol., Hagerstown, v.10, Suppl 1, p.23-27, 1998.
53. SUNG, E. C. Dental management of patients undergoing chemotherapy. J. Calif. Dent. Assoc., Sacramento, v.3, n.11, p.55-59, 1995.
54. SWEENEY, M, P. et al. Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol., Kidlington, v.34, n.2, p.123-126, 1998.
55. TOTH, B. B. et al. Minimizing oral complications of cancer treatment. Oncology, Basel, v.9, n.9, p.851-858, 1995.
56. VIDAL, A. M. et al. Anaerobic bacteremia in a neutropenic patient with oral mucositis. Am. J. Med. Sci., Philadelphia, v.319, n.3, p.189-190, 2000.
57. XAVIER, G. The importance of mouth care in preventing infection. Nurs. Stand., Cardiff, v.14, n.18, p.47-52, 2000.
58. WILKES, J. D. Prevention and treatment of oral mucositis following cancer chemotherapy. Semin. Oncol., Philadelphia, v.25, n.5, p.538-551, 1998.